T2 Biosystems, Inc. Deferred Tax Assets, Valuation Allowance
T2 Biosystems, Inc. had Deferred Tax Assets, Valuation Allowance of $87.24 million as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2024-04-01
- 2023-12-31: Deferred Tax Assets, Valuation Allowance $87.24M.
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $87.84M.
- 2021-12-31: Deferred Tax Assets, Valuation Allowance $84.80M.
- 2020-12-31: Deferred Tax Assets, Valuation Allowance $72.40M.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2023-12-31 | $87.24M 10-K · filed 2024-04-01 | |
| 2022-12-31 | $87.84M 10-K · filed 2024-04-01 | |
| 2021-12-31 | $84.80M 10-K · filed 2023-03-31 | |
| 2020-12-31 | $72.40M 10-K · filed 2022-03-23 | |
| 2019-12-31 | $59.76M 10-K · filed 2021-03-31 | $104.20M 10-K · filed 2020-03-16 |
| 2018-12-31 | $90.36M 10-K · filed 2020-03-16 | |
| 2017-12-31 | $77.55M 10-K · filed 2019-03-14 | |
| 2016-12-31 | $83.92M 10-K · filed 2018-03-19 | |
| 2015-12-31 | $61.81M 10-K · filed 2017-03-15 | |
| 2014-12-31 | $42.87M 10-K · filed 2016-03-09 | |
| 2013-12-31 | $30.15M 10-K · filed 2015-03-04 |